Medical/Pharmaceuticals

Chindex International, Inc. to Report Fourth Quarter and Full Year 2012 Financial Results

BETHESDA, Md., Feb. 27, 2013 /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX), an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today an...

2013-02-27 22:00 640

Christiana Care Health System partners with ColdLight Solutions and Medecision for Bridging the Divides care model

WILMINGTON, Del., Feb. 26, 2013 /PRNewswire/ -- Christiana Care Health System has partnered with ColdLight and Medecision to provide more coordinated personalized care to patients with chronic heart disease with breakthrough analytics technology. Christiana Care Health System has partnered with Col...

2013-02-27 12:38 616

Cliantha Research Partners with Acceliant for its Clinical Trials

BANGALORE, India, Feb. 27, 2013 /PRNewswire/ -- Acceliant( http://www.acceliant.com ), a global technology provider of innovative clinical trial data management( http://www.acceliant.com/about-us/acceliant-clinical-trials-platform.php ) solutions, today announced that Cliantha Research( http://ww...

2013-02-27 10:00 1111

Free Download -- QbD Implementation for Pharma Companies

SHANGHAI, Feb. 27, 2013 /PRNewswire/ -- Organized by CPhI Conferences, Quality by Design( http://www.qbd-china.com/Default.aspx?lang=en-us ) China 2013will take place on17-18 April in Shanghai. The organizer has announced that more than 15 professional people have been invited to be speakers, includ...

2013-02-27 08:00 1605

Solta Medical Completes Acquisition Of Sound Surgical Technologies

HAYWARD, Calif., Feb. 27, 2013 /PRNewswire/ -- Solta Medical, Inc. (Solta) (NASDAQ: SLTM) today announced the completion of its acquisition of privately-held Sound Surgical Technologies. The transaction is expected to be accretive within 12 months. "With this acquisition, we have added another st...

2013-02-27 05:30 1051

Mindray Announces 2012 Fourth Quarter and Full Year Results

SHENZHEN, China, Feb. 25, 2013 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 20...

2013-02-26 06:00 714

Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal

WASHINGTON and CRANBURY, New Jersey, Feb. 26, 2013 /PRNewswire/ -- Viropro, Inc. (OTC: VPRO) and Oncobiologics, Inc. announced today the signing of a biosimilar collaboration agreement. Under the agreement, Viropro will have the rights to manufacture six monoclonal antibody products being developed...

2013-02-26 00:50 656

ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders

SHANGHAI, Feb. 25, 2013 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) (the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it has called an extraordinary general meeting of shareholders (the "EGM"), to be hel...

2013-02-25 20:00 782

Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013

NANJING, China, Feb. 25, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financ...

2013-02-25 18:00 652

Know How Industry Experts Think About The Future of Generics

SHANGHAI, Feb. 25, 2013 /PRNewswire/ -- Currently, the global generic drug market has a value of 80 billion US dollars, making up over 40% of the overall global drug market, and is growing at a rate of 8% annually while the generic drug industry of China is growing at a tremendous rate of 25%. As th...

2013-02-25 08:00 1033

State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride

Phase I of clinical studies set to begin in the first half of 2013 Sihuan Pharmaceutical to further expand therapeutic area coverage HONG KONG, Feb. 22, 2013 /PRNewswire/ -- Sihuan Pharmaceutical( http://www.sihuanpharm.com ) Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Co...

2013-02-22 19:37 1474

Global manufacturer and distributor of high quality infection control products proudly unveils a new global brand identity

MONTREAL, Feb. 22, 2013 /PRNewswire/ -- A.R. Medicom(R) Inc. celebrates 25 years as a leading manufacturer and distributor of high quality infection control products with the unveiling of a new global brand identity that reflects the Company's position as a worldwide organization and elevates the br...

2013-02-22 07:26 1962

Bioscience Managers Expands Asia Pac Presence -- Invests NZ$3m in NZ Patient Monitoring Company

MELBOURNE, Australia, Feb. 21, 2013 /PRNewswire/ -- Leading Asia Pacific healthcare fund manager, BioScience Managers Pty Ltd, today announced a NZ$3m investment in innovative New Zealand asthma technology company Nexus6. Nexus6's SmartInhaler product remotely monitors adherence to asthma treatment...

2013-02-21 21:00 825

Boston Scientific Signs Agreement with Fukuda Denshi for Distribution of Neuromodulation Devices in Japan

TOKYO, Feb. 21, 2013 /PRNewswire/ -- (Feb. 20, 2013 US Time) Boston Scientific Corporation (NYSE: BSX) subsidiary Boston Scientific Japan K.K. has reached an agreement with Fukuda Denshi Co., Ltd. to market and sell the Boston Scientific Spinal Cord Precision Plus System and accessories throughout J...

2013-02-21 08:00 1034

Simbionix Signs an Agreement with the Laparoscopic Surgical Skills Foundation (LSS)

CLEVELAND, Ohio, Feb. 21, 2013 /PRNewswire/ -- Simbionix and the Laparoscopic Surgical Skills Foundation (LSS) signed a collaboration agreement that is supported by Europe's most prestigious society in the laparoscopic discipline, The European Association for Endoscopic Surgery (EAES). Training mate...

2013-02-21 07:33 891

China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results

HONG KONG, Feb. 19, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2013 on Tuesday, February 26, 2013, after market close in the US. The Company ...

2013-02-19 18:00 707

Neurim Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of Piromelatine for the Treatment of Insomnia

ZURICH, Feb. 18, 2013 /PRNewswire/ -- Neurim Pharmaceuticals announced today positive results from a phase II clinical study evaluating the efficacy and safety of Piromelatine (Neu-P11), a novel investigational multimodal sleep medicine developed for the treatment of patients with primary and co-mor...

2013-02-18 06:00 1747

TPI to Hold 2012 Shareholder Annual Meeting on May 8, 2013 In New York City

CHENGDU, China, Feb. 15, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that ...

2013-02-16 12:09 686

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 Financial Results

WEIFANG, SHANDONG, China, Feb. 14, 2013 /PRNewswire/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) (''Shengtai'' or ''the Company'' or "We" or "Us" or "Our"), a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose prod...

2013-02-15 10:18 1081

TPI Reports Second Quarter Fiscal Year 2013 Financial Results

CHENGDU, China, Feb. 14, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial re...

2013-02-14 18:55 986
1 ... 335336337338339340341 ... 399